AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimaday 1mg/500mg Tablet ER

Prescription Icon
Prescription Required

Marketer

Wockhardt Ltd

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Glimaday 1mg/500mg Tablet ER

Diabex Duo 1mg/500mg Extended-Release tablets are classified as antidiabetic medications. This dual-action formulation combines two drugs to manage type 2 diabetes in adults, effectively regulating blood glucose. Diabex Duo should be ingested with food, consistently at the same time daily for optimal efficacy. Dosage is determined individually by your physician and may be adjusted based on blood sugar monitoring. Continuous use is crucial, even with controlled blood sugar, as abrupt cessation can lead to elevated glucose levels, increasing the risk of complications including kidney impairment, vision loss, neuropathy, and limb amputation. This medication forms part of a comprehensive diabetes management plan incorporating a balanced diet, regular physical activity, and weight management as directed by your doctor. Lifestyle choices are paramount in diabetes control. The most frequent adverse effect is hypoglycemia (low blood sugar). Learn to recognize symptoms like sweating, lightheadedness, headache, and tremors, and know how to treat them. Regular meals and readily available fast-acting glucose sources (e.g., sugary snacks or juice) are essential preventative measures. Alcohol consumption should be minimized due to its potential to exacerbate hypoglycemia. Additional potential side effects include altered taste perception, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur in some patients. This medication is contraindicated in individuals with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Consult your doctor before use during pregnancy or breastfeeding. Regular blood glucose monitoring is necessary, and additional blood tests to assess blood cell counts and liver function may be recommended.

Primary Ingredients of Glimaday 1mg/500mg Tablet ER

No text provided to rephrase.

Uses of Glimaday 1mg/500mg Tablet ER

Managing type 2 diabetes

Major Benefits of Glimaday 1mg/500mg Tablet ER:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the entire tablet without chewing, crushing, or breaking it. Consume Glimaday 1mg/500mg Extended-Release tablets with food.

Common Side effects of Glimaday 1mg/500mg Tablet ER:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimaday 1mg/500mg Tablet ER:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the entire tablet; do not crush, chew, or divide it. Consume Glimaday 1mg/500mg Extended-Release tablets with a meal.

How Glimaday 1mg/500mg Tablet ER works:

Glimepiride/Metformin Extended-Release tablets (1mg/500mg) combine two distinct antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thus reducing blood sugar levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol use with Glimaday 1mg/500mg Extended-Release tablets is contraindicated.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release Glimaday (1mg/500mg) tablets might pose pregnancy risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Extended-release Glimaday (1mg/500mg) tablets are contraindicated for breastfeeding mothers. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood sugar levels. Refrain from driving if you experience such symptoms.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glimaday 1mg/500mg Extended-Release tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates Glimaday 1mg/500mg ER tablet use. Physician consultation is recommended. Regular kidney function monitoring is advised during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glimaday 1mg/500mg Extended-Release tablets cautiously. Dosage modification may be necessary. Consult your physician. For those with mild to moderate liver disease, a low starting dose is typical; however, Glimaday 1mg/500mg Extended-Release tablets are not advised for individuals with severe liver disease.

What if you forget to take Glimaday 1mg/500mg Tablet ER :

Should you forget a Glimaday 1mg/500mg Extended-Release tablet, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimaday 1mg/500mg Tablet ER

LabelValue
Developing Habits No.
Type of Therapy Diabetes Management

FAQs on Glimaday 1mg/500mg Tablet ER

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Glimaday 1mg/500mg Tablet ER can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but dangerous side effect is more likely in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Glimaday 1mg/500mg Tablet ER and seek immediate medical attention.
Glimepiride/Metformin (Glimaday 1mg/500mg ER) tablets treat type 2 diabetes mellitus in adults. This combination medication improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. This treatment is not suitable for type 1 diabetes.
Glimaday 1mg/500mg ER tablets may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use may also result in vitamin B12 deficiency.
Prolonged use of Glimaday 1mg/500mg Tablet ER can lead to vitamin B12 deficiency by impairing its absorption. This deficiency, if left untreated, may result in anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and ataxia), urinary issues, and cognitive changes. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Glimaday 1mg/500mg ER Tablets can cause hypoglycemia (low blood sugar). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and anxiety or shakiness. Hypoglycemia risk increases if you skip meals, drink alcohol, overexert yourself, or take other diabetes medications concurrently. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Glimaday 1mg/500mg ER tablets with alcohol is unsafe. This combination can cause dangerously low blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Glimaday 1mg/500mg Tablet...
107
MRP 124
13% off